Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers.
On August 11, 2021, Mr. Christopher Gaulin resigned as Chief Executive Officer
and a director of HealthCor Catalio Acquisition Corp., a Cayman Islands exempted
company (the "Company"). Mr. Gaulin has served as Chief Executive Officer and a
director since the Company's initial public offering. His resignation was not
due to any disagreement with the Company. On August 11, 2021, the board of
directors of the Company (the "Board") appointed Mr. Art Cohen to serve as the
Chief Executive Officer of the Company and as a director, effective immediately.
Mr. Cohen, age 59, is a co-founder and portfolio manager of HealthCor
Management, L.P. ("HealthCor"). Prior to HealthCor, Mr. Cohen was a portfolio
manager at S.A.C. Capital Advisors, LLC ("SAC") from January 2000 through March
2005. Prior to SAC, from 1995 to 2000, Mr. Cohen was responsible for healthcare
investments as a managing director at Tiger Management. Prior to Tiger
Management, from 1993 to 1995, Mr. Cohen was a vice president and investment
officer at JW Seligman, a vice president at Bank of New York from 1991 to 1993,
and an assistant portfolio manager/analyst of the MSB Fund from 1987 to 1991.
Mr. Cohen graduated from the University of Virginia in 1983 with a B.A. in
commerce and received his M.B.A. in banking and finance from Hofstra University
in 1986. We believe that Mr. Cohen's transactional and investing experience in
the healthcare industry make him well qualified to serve on our board of
directors.
There are no family relationships between Mr. Cohen and any director, executive
officer, or person nominated or chosen by the Company to become an executive
officer of the Company. There are no transactions between the Company and Mr.
Cohen that are subject to disclosure under Item 404(a) of Regulation S-K.
Additionally, on August 11, 2021, Mr. Avi Horev resigned as a director of the
Company. Mr. Horev has served as a director on the Board since the Company's
initial public offering. His resignation was not due to any disagreement with
the Company. On August 11, 2021, the Board appointed Mr. Benjamin Snedeker, age
45, to serve as a director on the Board. There are no transactions between the
Company and Mr. Snedeker that are subject to disclosure under
Item 404(a) of Regulation S-K.
© Edgar Online, source Glimpses
HEAR CATA 
